206 related articles for article (PubMed ID: 21390007)
1. Elias Zerhouni.
Zerhouni E
Nat Biotechnol; 2011 Mar; 29(3):188. PubMed ID: 21390007
[No Abstract] [Full Text] [Related]
2. Anthony Coyle.
Coyle A
Nat Biotechnol; 2011 Mar; 29(3):187. PubMed ID: 21390006
[No Abstract] [Full Text] [Related]
3. Never again.
Scott C
Nat Biotechnol; 2010 Feb; 28(2):131. PubMed ID: 20139946
[No Abstract] [Full Text] [Related]
4. A very firm handshake: biotech's growing negotiating power.
Thiel KA
Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058
[No Abstract] [Full Text] [Related]
5. Best of both worlds.
Smaglik P
Nature; 2003 Dec; 426(6967):706-7. PubMed ID: 14668875
[No Abstract] [Full Text] [Related]
6. Biotechnology partnerships--medicine for an ailing industry?
DeLamarter J
Nat Biotechnol; 2003 Aug; 21(8):847-8. PubMed ID: 12894192
[No Abstract] [Full Text] [Related]
7. Antiinfective biotechs face partnering gap.
Sheridan C
Nat Biotechnol; 2005 Feb; 23(2):155-6. PubMed ID: 15696131
[No Abstract] [Full Text] [Related]
8. Earlier stage biotechs attract partners.
Ratner M
Nat Biotechnol; 2005 May; 23(5):509. PubMed ID: 15877052
[No Abstract] [Full Text] [Related]
9. Paths to entrepreneurship in the life sciences.
Mehta S
Nat Biotechnol; 2004 Dec; 22(12):1609-12. PubMed ID: 15605429
[No Abstract] [Full Text] [Related]
10. Does biotech M&A benefit investors?
Jacobs T
Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
[No Abstract] [Full Text] [Related]
11. Genentech makes its first-ever acquisition.
Hollmer M
Nat Biotechnol; 2007 Jan; 25(1):4-5. PubMed ID: 17211375
[No Abstract] [Full Text] [Related]
12. Michigan's next wave of biopharmaceutical entrepreneurship.
Kerppola R; van de Walle M; Surine S
Nat Biotechnol; 2003 Sep; 21(9):1109-11. PubMed ID: 12949575
[No Abstract] [Full Text] [Related]
13. Swedish roadtrip.
Herrera S
Nat Biotechnol; 2006 Jan; 24(1):15. PubMed ID: 16475247
[No Abstract] [Full Text] [Related]
14. A reprise for collaborative financing in biotech.
Ransom J
Nat Biotechnol; 2006 Aug; 24(8):873-4. PubMed ID: 16900110
[No Abstract] [Full Text] [Related]
15. Trials and error.
Jacobs T
Nat Biotechnol; 2005 Dec; 23(12):1481. PubMed ID: 16333284
[No Abstract] [Full Text] [Related]
16. Biotechs follow big pharma lead back into academia.
Kling J
Nat Biotechnol; 2011 Jul; 29(7):555-6. PubMed ID: 21747364
[No Abstract] [Full Text] [Related]
17. The best companies bare all.
Jacobs T
Nat Biotechnol; 2004 Nov; 22(11):1363. PubMed ID: 15529156
[No Abstract] [Full Text] [Related]
18. Is Elan a turnaround?
Jacobs T
Nat Biotechnol; 2003 Sep; 21(9):985. PubMed ID: 12949557
[No Abstract] [Full Text] [Related]
19. Academic-industrial relationships in the life sciences.
Blumenthal D
N Engl J Med; 2003 Dec; 349(25):2452-9. PubMed ID: 14681513
[No Abstract] [Full Text] [Related]
20. In search of the élite.
Gewin V
Nature; 2003 Dec; 426(6967):713-7. PubMed ID: 14668879
[No Abstract] [Full Text] [Related]
[Next] [New Search]
